Wai Yuen Tong Medicine Holdings Ltd. provided consolidated earnings guidance for the six months ended September 30, 2012. The company announced that the Group is expected to report a turn from a loss to a profit for the period as compared to the corresponding period in 2011. Such expected profit was mainly attributable to, among other things, the increase in gain on change in fair value of investment properties, the decrease in the net realised and unrealised loss on held-for-trading investments and the lack of impairment losses recognised for the investment in an associate as compared to the corresponding period in 2011.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.243 HKD | +6.11% |
|
+13.02% | -39.25% |
1st Jan change | Capi. | |
---|---|---|
-39.25% | 32.99M | |
+29.99% | 5.69B | |
-31.99% | 3.53B | |
-0.59% | 3.06B | |
-24.15% | 2.62B | |
-9.23% | 2.29B | |
+42.55% | 1.86B | |
+44.37% | 1.43B | |
-11.29% | 1.41B | |
+42.86% | 1.4B |
- Stock Market
- Equities
- 897 Stock
- News Wai Yuen Tong Medicine Holdings Limited
- Wai Yuen Tong Medicine Holdings Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2012